Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
Amina Aït-Ammar, Anna Kula, Gilles Darcis, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

The cell biology of HIV-1 latency and rebound
Uri Mbonye, Jonathan Karn
Retrovirology (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 16
The Current Status of Latency Reversing Agents for HIV-1 Remission
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 96
The multifaceted nature of HIV latency
Caroline Dufour, Pierre Gantner, Rémi Fromentin, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3381-3390
Open Access | Times Cited: 72
Toward a cure – Advancing HIV/AIDs treatment modalities beyond antiretroviral therapy: A Review
Esther Ugo Alum, Daniel Ejim Uti, Okechukwu Paul-Chima Ugwu, et al.
Medicine (2024) Vol. 103, Iss. 27, pp. e38768-e38768
Open Access | Times Cited: 8
Block and Lock HIV Cure Strategies to Control the Latent Reservoir
Chantelle Ahlenstiel, Geoff Symonds, Stephen J. Kent, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 56
The multifaceted nature of HIV latency
Caroline Dufour, Pierre Gantner, Rémi Fromentin, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 11
Open Access | Times Cited: 55
Management of epigenomic networks entailed in coronavirus infections and COVID-19
Ranim El Baba, Georges Herbein
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Non-Thermal Plasma as a Novel Strategy for Treating or Preventing Viral Infection and Associated Disease
Hager Mohamed, Gaurav Nayak, Nicole Rendine, et al.
Frontiers in Physics (2021) Vol. 9
Open Access | Times Cited: 50
Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies
Tram M. Ta, Sajjaf Malik, Elizabeth M. Anderson, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 35
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo
Jin‐Hee Kim, Deepanwita Bose, Mariluz Araínga, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG)
Huachao Huang, Weili Kong, Maxime Jean, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 14, pp. 7333-7347
Open Access | Times Cited: 45
Engineering CAR T Cells to Target the HIV Reservoir
Wenli Mu, Mayra A. Carrillo, Scott G. Kitchen
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 40
CBX4 contributes to HIV‐1 latency by forming phase‐separated nuclear bodies and SUMOylating EZH2
Liyang Wu, Ting Pan, Mo Zhou, et al.
EMBO Reports (2022) Vol. 23, Iss. 7
Open Access | Times Cited: 25
Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir
Weiwei Dai, Fengting Wu, Natalie F. McMyn, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 667
Open Access | Times Cited: 25
Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury
Kazuo Suzuki, John Zaunders, Thomas M. Gates, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 48
Open Access | Times Cited: 25
Enhancing HIV-1 latency reversal through regulating the elongating RNA Pol II pause-release by a small-molecule disruptor of PAF1C
Shimaa Soliman, William J. Cisneros, Marta Iwanaszko, et al.
Science Advances (2023) Vol. 9, Iss. 10
Open Access | Times Cited: 15
Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies
Marija Rozman, Snježana Židovec Lepej, Karlo Jambrosic, et al.
Pathogens (2023) Vol. 12, Iss. 1, pp. 92-92
Open Access | Times Cited: 13
Development and characterization of a double-fluorescent HIV-1 reporter cellular model to tackle the Rev-dependent export pathway
Jakub Wadas, Haider Ali, A Osiecka, et al.
Microbiology Spectrum (2025)
Open Access
Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency
Alexandra Dorman, Maryam Bendoumou, Aurelija Valaitienė, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal
Carley N Gray, Manickam Ashokkumar, Derek H. Janssens, et al.
(2025)
Open Access
Integration of long-acting antiretroviral therapies and latency-reversing agents for reservoir reduction and viral suppression: a comprehensive review
Saksham Sharma, Udithi Bandaru, C Soni, et al.
InterConf (2025), Iss. 53(232), pp. 258-270
Closed Access
GS143, an inhibitor of E3 ligase β-TrCP, reverses HIV-1 latency without activating T cells via unconventional activation of NFκB
Srijata Sarkar, Yoshifumi Kobayashi, Timothy Russnak, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1013018-e1013018
Open Access
A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency
Manickam Ashokkumar, Terry L Hafer, Abby Felton, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1012467-e1012467
Open Access
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs ex vivo
Ayako Sedohara, Tomohiko Koibuchi, Makoto Yamagishi, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Integrator complex subunit 12 knockout overcomes a transcriptional block to HIV latency reversal
Carley N Gray, Manickam Ashokkumar, Derek H. Janssens, et al.
eLife (2025) Vol. 13
Open Access
Page 1 - Next Page

Scroll to top